# Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis

> **NCT02761993** · PHASE2 · COMPLETED · sponsor: **Noveome Biotherapeutics, formerly Stemnion** · enrollment: 151 (actual)

## Conditions studied

- Periodontal Disease

## Interventions

- **BIOLOGICAL:** ST266
- **DRUG:** Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT02761993
- **Lead sponsor:** Noveome Biotherapeutics, formerly Stemnion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02761993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02761993, "Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02761993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*